Home MarketXLS
Dashboard MarketXLS
Screener MarketXLS
Options Profit Calculator MarketXLS
Stock Ranks MarketXLS
Spreadsheet Builder MarketXLS
Documentation MarketXLS
Logout MarketXLS
Aytu BioScience Inc. logo

Aytu BioScience Inc.

Sector: Healthcare   

Industry: Biotechnology

3.28
 
USD
  
0.11
  
(3.47%)
Optionable: Yes  Market Cap: 17 M  90-day average vol: 23,606

Previous close: 3.17  Open: 3.19  Bid: 3.14  Ask: 3.5
52 week range    
1.38   
   3.50
Peers   
ROL / 
CGEM / 
NAUH / 
Last updated: Wednesday 21st February 2024
63
MarketXLS Rank
40
Value
100
Technical
50
Quality

Get Access to 1 Billion Usable Market data points IN YOUR EXCEL SHEETS WITH EASY TO USE EXCEL FUNCTIONS

Get started today
Search for a stock

🎉 Exciting news! 🎉

You are invited to join our Discord Channel.

Interact, learn, and grow with experts in the markets!

Join our Discord

Financials

AYTU Income Statement

Annual
Aug-13Jun-15Jun-16Jun-17Jun-18Jun-19Jun-20Jun-21Jun-22Jun-23
Amortization of intangibles90662.0664707.02 M2 M2 M4 M6 M6 M5 M
Basic EPS from continuing operations-67.8-5.11
Basic EPS total-7.4-67.8-5.11
Basic weighted shares outstanding5 M460395.087056.023301.0665605.0389724.02 M837333.01 M3 M
Cost of sales-88109.0-957076.0-1 M-2 M-2 M8 M36 M44 M41 M
Depreciation-58351.0-27000.0-51000.0-134000.0-294000.0-100000.0-100000.0-600000.09 M7 M
Depreciation unreconciled90662.0664707.02 M2 M2 M4 M6 M6 M5 M
DepreciationAndAmortization-58351.090662.0664707.02 M2 M2 M4 M6 M6 M5 M
Diluted EPS total-0.01-16.8-323.6-966.0-15.31-69.6-6.0-69.6-75.0-5.11
Diluted normalized net income/share-6.0-69.6-75.0-5.11
Diluted weighted shares outstanding6 M459726.087083.023300.0665438.0389826.02 M837333.01 M3 M
Earnings from equity interest212809.0
EarningsFromEquityInterestNetOfTax212809.0
Fees20000.020000.0
GainOnSaleOfBusiness-10 M
GainOnSaleOfPPE4 M80779.0-100000.0100000.0
GainOnSaleOfSecurity-21800.0-971629.0-61519.0-1 M-16000.02000.02 M5 M
GeneralAndAdministrativeExpense47984.0-51000.0-120000.0-139000.0-142000.0-100000.020 M26 M31 M29 M
Gross operating profit1750.0-137331.01 M-2 M-2 M5 M19 M29 M52 M67 M
ImpairmentOfCapitalAssets8 M1 M2 M200000.013 M66 M6 M
Income before tax-57318.0-8 M-28 M-23 M-10 M-27 M-14 M-58 M-109 M-17 M
Income restructuring and M&A-6 M-6 M-2 M38 M700000.05 M
Income taxes300.0-23910.0-6000.0-100000.0-101000.0-192000.0-50000.0259000.0-110000.0-126000.0
Interest income-10 M10 M4 M
InterestExpenseNonOperating4904.0114994.05 M3 M749423.0535500.03 M-6000.014000.09000.0
InterestIncomeOperating-12572.0
MiscOtherSpecialCharges620325.0620325.03 M10 M7 M-3 M-4 M-588000.0-5 M
Net income from total operations-57318.0-8 M-28 M-23 M-10 M-27 M-14 M-58 M-109 M-17 M
NetIncomeCommonStockholders-57318.0-8 M-28 M-23 M-10 M-27 M-14 M-58 M-109 M-17 M
NetIncomeContinuousOperations-57318.0-8 M-28 M-23 M-10 M-27 M-14 M-58 M-109 M-17 M
NetNonOperatingInterestIncomeExpense-4904.0-114994.0-5 M-3 M-749423.0-10 M8 M4 M-14000.0-9000.0
NetOperatingInterestIncomeExpense-114994.0
Normalized income-19 M
Operating income-52414.0-8 M-14 M-22 M-22 M-17 M-18 M-38 M-38 M-13 M
Operating income before depreciation (EBITDA)-47472.0-7 M-17 M-15 M-7 M-24 M-7 M-49 M-99 M-8 M
OperatingExpense54164.0-8 M-24 M-23 M-23 M-24 M37 M67 M162 M84 M
Other income net21800.0-1 M971629.0-3 M-14 M-80779.0-5 M7 M9 M6 M
Other special charges44 M
OtherGandA47984.0-51000.0-120000.0-139000.0-142000.0-100000.020 M26 M31 M29 M
OtherImpairmentOfCapitalAssets195278.010 M6 M
OtherOperatingExpenses6180.0203992.0191991.0387960.0-476000.02 M969000.0
OtherWriteOff-11 M-13 M
PromotionAndAdvertising-5 M-15 M14 M11 M
RentAndLandingFees29904.0-51000.0-120000.0-139000.0-142000.0-100000.0-200000.0
Research & development expense3 M6 M959857.0167595.0589072.02 M6 M13 M4 M
ResearchExpense3 M6 M959857.0167595.0589072.02 M6 M13 M4 M
RestructringAndMnAIncome-6 M-6 M-2 M38 M700000.05 M
Revenue per share90662.0664707.02 M2 M2 M4 M6 M6 M5 M
SalariesAndWages203992.0-903000.0-3 M-597000.0-1 M-1 M-4 M5 M6 M
Selling Gen & administrative expense47984.04 M9 M17 M18 M19 M31 M56 M70 M70 M
SellingAndMarketingExpense4 M9 M17 M18 M19 M11 M30 M39 M41 M
SellingExpense4 M9 M17 M18 M19 M11 M30 M
Special income/charges6 M-7 M-1 M-2 M-38 M-900000.0-18 M-66 M-6 M
Total Income available for interest expense (EBIT)-52414.0-8 M-23 M-20 M-9 M-27 M-14 M-58 M-109 M-17 M
Total common shares outstanding5 M50.050.050.02 M88440.0629186.01 M3 M6 M
Total net income-57318.0-8 M-28 M-23 M-10 M-27 M-14 M-58 M-109 M-17 M
Total ordinary shares6 M6 M6 M6 M6 M6 M6 M6 M6 M6 M
Total revenues1750.0261782.03 M3 M4 M7 M28 M66 M97 M107 M
TotalExpenses54164.0-8 M-25 M-25 M-25 M-26 M46 M104 M207 M124 M
TotalRevenue1750.0261782.03 M3 M4 M7 M28 M66 M97 M107 M
Call: 1-877-778-8358
Ankur Mohan MarketXLS
Welcome! I'm Ankur, the founder and CEO of MarketXLS. With more than ten years of experience, I have assisted over 2,500 customers in developing personalized investment research strategies and monitoring systems using Excel.

I invite you to book a demo with me or my team to save time, enhance your investment research, and streamline your workflows.
Implement “your own” investment strategies in Excel with thousands of MarketXLS functions and templates.

We respect your privacy and will never share your email.
MarketXLS is a complete Excel stock solution

Kevin Hsu

StockKevin.com

I have used lots of stock and option information services. This is the only one which gives me what I need inside Excel

Lloyd Lenase

Option Day Trader

MarketXLS is a data junkie’s dream. It gives me the flexibility to mine for hidden treasures.

Dave

Swing trader since 2011

I like to access historical closing prices on a particular date. That makes tracking performance easy.

Patrick Cusatis, Ph.D., CFA

Associate Professor of Finance - Penn State University